JAMA: Immunogenicity of COVID-19 mRNA vaccine in pregnant and lactating women

Compared with other women of childbearing age, pregnant women with COVID-19 symptoms are at higher risk of admission, mechanical ventilation and death in the intensive care unit.

The theoretical risk of vaccinating the COVID-19 vaccine during pregnancy and lactation is limited.

The new genetic variation is evolved from the original sequence of SARS-CoV-2.

Ai-ris Y.

The study included 30 pregnant women, 16 breastfeeding women and 57 women who were neither pregnant nor breastfeeding.

The study included 103 women between the ages of 18 and 45 (66% non-Hispanic whites) who received the COVID-19 mRNA vaccine.

The COVID-19 mRNA vaccine is immunogenic, quantified by humoral and cellular immune responses, and is suitable for pregnant, lactating and non-pregnant women.

Consistent with recent reports, serum neutralizing antibody titers were significantly reduced, for the B.

In summary, pregnant women receiving the COVID-19 mRNA vaccine are immunogenic, and the antibodies caused by the vaccine are transported to the baby's cord blood and breast milk.

com/journals/jama/fullarticle/2780202" target="_blank" rel="noopener">Collier AY, McMahan K, Yu J, et al.